Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Iva Mucalo is active.

Publication


Featured researches published by Iva Mucalo.


Journal of Ethnopharmacology | 2013

Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension.

Iva Mucalo; Elena Jovanovski; Dario Rahelić; Velimir Božikov; Željko Romić; Vladimir Vuksan

ETHNOPHARMACOLOGICAL RELEVANCE Substantial pre-clinical and some clinical data are available showing that Asian ginseng (Panax ginseng C.A. Meyer) varieties or its particular ginsenosides exert a vasodilatating effect, thus may modulate vascular function. However, the clinical evidence for American ginseng (Panax quinquefolius L.) is scarce. Therefore, this study evaluates the effect of American ginseng (AG) on arterial stiffness, as measured by augmentation index (AI), and blood pressure (BP), in type 2 diabetes patients with concomitant hypertension. MATERIALS AND METHODS Using a double-blind, placebo-controlled, parallel design, each participant was randomized to either the selected AG extract or placebo at daily dose of 3g for 12 weeks as an adjunct to their usual antihypertensive and anti-diabetic therapy (diet and/or medications). AI and BP were measured by applanation tonometry at baseline and after 12 weeks of treatment. RESULTS A total of 64 individuals with well-controlled essential hypertension and type 2 diabetes (gender: 22 M:42 F, age:63 ± 9.3 years, BP: 145 ± 10.8/84 ± 8.0 mmHg, HbA1c: 7.0 ± 1.3%, fasting blood glucose (FBG): 8.1 ± 2.3 mmol/L) completed the study. Compared to placebo, 3g of AG significantly lowered radial AI by 5.3% (P=0.041) and systolic BP by 11.7% (P<0.001) at 12 weeks. No effect was observed with diastolic BP. CONCLUSIONS Addition of AG extract to conventional therapy in diabetes with concomitant hypertension improved arterial stiffness and attenuated systolic BP, thus warrants further investigation on long-term endothelial parameters before recommended as an adjunct treatment.


The American Journal of Pharmaceutical Education | 2012

Individualized Education and Competency Development of Croatian Community Pharmacists Using the General Level Framework

Arijana Meštrović; Z Staničić; Maja Ortner Hadžiabdić; Iva Mucalo; Ian Bates; Catherine Duggan; Sarah Carter; Andreia Bruno; M Košiček

Objectives. To measure Croatian community pharmacists’ progress in competency development using the General Level Framework (GLF) as an educational tool in a longitudinal study. Methods. Patient care competencies of 100 community pharmacists were evaluated twice, in 2009 and in 2010 in a prospective cohort study. During this 12-month period, tailored educational programs based on the GLF were organized and conducted, new services and standard operating procedures were implemented, and documentation of contributions to patient care in the pharmacist’s portfolio became mandatory. Results. Pharmacists’ development of all GLF patient care competencies was significant with the greatest improvements seen in the following competencies: patient consultation, monitoring drug therapy, medicine information and patient education, and evaluation of outcomes. Conclusions. This study, which retested the effectiveness of an evidence-based competency framework, confirmed that GLF is a valid educational tool for pharmacist development.


Croatian Medical Journal | 2011

Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study

Nikica Mirošević Skvrce; Viola Macolić Šarinić; Iva Mucalo; Darko Krnić; Nada Božina; Siniša Tomić

Aim To analyze potential and actual drug-drug interactions reported to the Spontaneous Reporting Database of the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and determine their incidence. Methods In this retrospective observational study performed from March 2005 to December 2008, we detected potential and actual drug-drug interactions using interaction programs and analyzed them. Results HALMED received 1209 reports involving at least two drugs. There were 468 (38.7%) reports on potential drug-drug interactions, 94 of which (7.8% of total reports) were actual drug-drug interactions. Among actual drug-drug interaction reports, the proportion of serious adverse drug reactions (53 out of 94) and the number of drugs (n = 4) was significantly higher (P < 0.001) than among the remaining reports (580 out of 1982; n = 2, respectively). Actual drug-drug interactions most frequently involved nervous system agents (34.0%), and interactions caused by antiplatelet, anticoagulant, and non-steroidal anti-inflammatory drugs were in most cases serious. In only 12 out of 94 reports, actual drug-drug interactions were recognized by the reporter. Conclusion The study confirmed that the Spontaneous Reporting Database was a valuable resource for detecting actual drug-drug interactions. Also, it identified drugs leading to serious adverse drug reactions and deaths, thus indicating the areas which should be in the focus of health care education.


Journal of Human Nutrition and Dietetics | 2015

Factors predictive of drop‐out and weight loss success in weight management of obese patients

M. Ortner Hadžiabdić; Iva Mucalo; P. Hrabač; Tomas Matić; Dario Rahelić; Velimir Božikov


Journal of The American Society of Hypertension | 2014

Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial.

Elena Jovanovski; Emma A. Bateman; Jyoti Bhardwaj; Chris Fairgrieve; Iva Mucalo; Alexandra L. Jenkins; Vladimir Vuksan


The American Journal of Pharmaceutical Education | 2011

Evaluation of Croatian community pharmacists' patient care competencies using the general level framework.

Arijana Meštrović; Živka Staničić; Maja Ortner Hadžiabdić; Iva Mucalo; Ian Bates; Catherine Duggan; Sarah Carter; Andreia Bruno


European Journal of Clinical Pharmacology | 2017

Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol

Iva Mucalo; Maja Ortner Hadžiabdić; Andrea Brajković; Sonja Lukić; Patricia Marić; Ivana Marinović; Vesna Bacic-Vrca


The American Journal of Pharmaceutical Education | 2016

The Development of the Croatian Competency Framework for Pharmacists

Iva Mucalo; Maja Ortner Hadžiabdić; Tihana Govorčinović; Martina Šarić; Andreia Bruno; Ian Bates


Archive | 2017

Uloga kliničkog farmaceuta u optimizaciji terapije bolesnika starije životne dobi- prikaz slučaja

Maja Ortner Hadžiabdić; Iva Mucalo


Archive | 2017

Razvoj i implementacija novog nastavnog kolegija Konzultacijske vještine Design and implementation of the new Consultation skills course

Maja Ortner Hadžiabdić; Iva Mucalo; Živka Juričić

Collaboration


Dive into the Iva Mucalo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Željko Romić

Clinical Hospital Dubrava

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian Bates

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge